Synovitis
Symptoms, Doctors, Treatments, Advances & More

Synovitis Overview

Save information for later
Sign Up

Learn About Synovitis

What is the definition of Synovitis?
Synovitis is the inflammation of a synovial membrane, the layer of connective tissue that lines joints such as the shoulder, hip, knee, or ankle. Arthritis is one of the main causes of synovitis. Athletes and individuals with physically rigorous jobs are also particularly at risk of overusing joints and developing synovitis. 
What are the symptoms of Synovitis?
The main symptom of synovitis is joint pain, which can range in severity from person to person. Some individuals experience significant paint even if there is no swelling or inflammation of the joint. Individuals with synovitis may also experience bleeding at the affected joint(s).
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Synovitis?
The simplest treatment for synovitis involves rest to avoid further joint damage. Individuals with synovitis may also be prescribed disease-modifying antirheumatic drugs (DMARDs) or receive oral steroids to reduce inflammation. Physical therapy may aid with strengthening a joint and surrounding muscles, and in more serious cases, a physician may recommend a synovectomy, a procedure to remove the inflamed joint lining. 
Who are the top Synovitis Local Doctors?
Distinguished in Synovitis
Dr. Edward J. Bieber
Hand Surgery | Orthopedics | Sports Medicine
Distinguished in Synovitis
Dr. Edward J. Bieber
Hand Surgery | Orthopedics | Sports Medicine
Referral may be required
Before you request

OrthoBethesda

10215 Fernwood Road, Suite 506, 
Bethesda, MD 
301-530-1010
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Edward Bieber is an Orthopedics specialist and a Sports Medicine provider practicing medicine in Bethesda, Maryland. Dr. Bieber is rated as a Distinguished provider by MediFind in the treatment of Synovitis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Synovitis, Tendinitis, Tenosynovitis, and Trigger Thumb. Dr. Bieber is board certified in Abos.

Elite in Synovitis
Dr. David T. Felson
Rheumatology
Elite in Synovitis
Dr. David T. Felson
Rheumatology
Referral may be required
Before you request

Office

725 Albany St Ste B, 
Boston, MA 
617-638-7460
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Felson is a Rheumatologist practicing medicine in Boston, Massachusetts. Dr. Felson is rated as an Elite provider by MediFind in the treatment of Synovitis. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Arthritis, Synovitis, Calcium Pyrophosphate Arthritis, Rheumatoid Arthritis (RA), and Knee Replacement. Dr. Felson is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Synovitis
Elite in Synovitis
Referral may be required
Copenhagen, DK 

Mikkel Ostergaard practices practicing medicine in Copenhagen, Denmark. Mr. Ostergaard is rated as an Elite expert by MediFind in the treatment of Synovitis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Tenosynovitis, Arthritis, Synovitis, and Rheumatoid Arthritis (RA).

View All Doctors
What are the latest Synovitis Clinical Trials?
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor (TGCT)
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor (TGCT)
Who is this study for: Child to adult patients with Recurrent or Refractory Solid Tumors or Acute Leukemia
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Drug
Study Drug: PLX3397
Study Phase: Phase 1

Background: \- Some people with cancer have solid tumors. Others have refractory leukemia. This may not go away after treatment. Researchers want to see if a drug called TURALIO(R) can shrink tumors or stop them from growing.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase 2, Single-arm Study to Investigate the Tolerability, Pharmacokinetics, Efficacy, and Safety of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor
Phase 2, Single-arm Study to Investigate the Tolerability, Pharmacokinetics, Efficacy, and Safety of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor
Enrollment Status: Recruiting
Publish Date: August 10, 2026
Intervention Type: Drug
Study Phase: Phase 2

Summary: The primary purpose of this study is to assess the tolerability, pharmacokinetics, and efficacy of pimicotinib in Japanese participants with TGCT

View All Clinical Trials